Serum Bcma May Interfere with Anti-Bcma-CAR-Transduced T Cells or Other Anti-Bcma Antibody-Based Immunotherapy in Multiple Myeloma
Sign Up to like & getrecommendations! Published in 2017 at "Blood"
DOI: 10.1182/blood.v130.suppl_1.4413.4413
Abstract: Introduction: CAR T cell-based immunotherapy has shown clinical activity in a variety of B-cell malignancies. Specifically, the engineered CAR-transduced T cells targeting B-cell maturation antigen (BCMA) on multiple myeloma (MM) have shown promising activity for… read more here.
Keywords: bcma; serum; bcma antibody; anti bcma ... See more keywords